Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations

Jiaying Deng,Hu Chen,Daizhan Zhou,Junhua Zhang,Yun Chen,Qi Liu,Dashan Ai,Hanting Zhu,Li Chu,Wenjia Ren,Xiaofei Zhang,Yi Xia,Menghong Sun,Huiwen Zhang,Jun Li,Xinxin Peng,Liang Li,Leng Han,Hui Lin,Xiujun Cai,Jiaqing Xiang,Shufeng Chen,Yihua Sun,Yawei Zhang,Jie Zhang,Haiquan Chen,Shijian Zhang,Yi Zhao,Yun Liu,Han Liang,Kuaile Zhao

DOI: https://doi.org/10.1038/s41467-017-01730-x

2017-11-16

Abstract:Esophageal squamous cell carcinoma is a major histological type of esophageal cancer, with distinct incidence and survival patterns among races. Although previous studies have characterized somatic mutations in this disease, a rigorous comparison between different patient populations has not been conducted. Here we sequence the samples of 316 Chinese patients, combine them with those from The Cancer Genome Atlas, and perform a comparative analysis between Asian and Caucasian patients. We find that mutated CSMD3 is associated with better prognosis in Asian patients. Applying a robust computational strategy that adjusts for both technical and biological confounding factors, we find that TP53, EP300, and NFE2L2 show higher mutational frequencies in Asian patients. Moreover, NFE2L2 mutations correlate with the allele status of a nearby high-Fst SNP, suggesting their potential interaction. Our study provides insights into the molecular basis underlying the striking racial disparities of this disease, and represents a general computational framework for such a cross-population comparison.